chr2-202635485-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_173511.4(FAM117B):āc.298A>Gā(p.Asn100Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000193 in 1,037,028 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_173511.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM117B | NM_173511.4 | c.298A>G | p.Asn100Asp | missense_variant | 1/8 | ENST00000392238.3 | NP_775782.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM117B | ENST00000392238.3 | c.298A>G | p.Asn100Asp | missense_variant | 1/8 | 1 | NM_173511.4 | ENSP00000376071.2 | ||
FAM117B | ENST00000481658.1 | n.-4A>G | upstream_gene_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.00000692 AC: 1AN: 144494Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.00000112 AC: 1AN: 892534Hom.: 0 Cov.: 31 AF XY: 0.00000240 AC XY: 1AN XY: 417376
GnomAD4 genome AF: 0.00000692 AC: 1AN: 144494Hom.: 0 Cov.: 31 AF XY: 0.0000142 AC XY: 1AN XY: 70282
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2021 | The c.298A>G (p.N100D) alteration is located in exon 1 (coding exon 1) of the FAM117B gene. This alteration results from a A to G substitution at nucleotide position 298, causing the asparagine (N) at amino acid position 100 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at